Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease.
about
Gut-Liver Axis Derangement in Non-Alcoholic Fatty Liver DiseaseNonalcoholic fatty liver disease: Evolving paradigms.Cholecystectomy: a way forward and back to metabolic syndrome?Biology and pathological implications of brown adipose tissue: promises and caveats for the control of obesity and its associated complications.Modulating bile acid pathways and TGR5 receptors for treating liver and GI diseases.Hepatic farnesoid X receptor protein level and circulating fibroblast growth factor 19 concentration in children with NAFLD.Dietary and metabolic modulators of hepatic immunity.Spexin Acts as Novel Regulator for Bile Acid Synthesis.Managing portal hypertension in patients with liver cirrhosis.Takeda G Protein-Coupled Receptor 5-Mechanistic Target of Rapamycin Complex 1 Signaling Contributes to the Increment of Glucagon-Like Peptide-1 Production after Roux-en-Y Gastric Bypass.Ileal Bile Acid Transporter Inhibition for the Treatment of Chronic Constipation, Cholestatic Pruritus, and NASHWeight-Independent Mechanisms of Glucose Control After Roux-en-Y Gastric BypassBile acid metabolites in early pregnancy and risk of gestational diabetes in Chinese women: A nested case-control studyDivergent effects of resistance and endurance exercise on plasma bile acids, FGF19, and FGF21 in humansAntibiotic-induced microbiome depletion alters metabolic homeostasis by affecting gut signaling and colonic metabolismUpdate on FXR Biology: Promising Therapeutic Target?Implication of gut microbiota metabolites in cardiovascular and metabolic diseases
P2860
Q41552497-15079A58-8D84-4194-BA1F-23E3FDAE76F8Q42695154-8290C061-25E0-4FB5-A3AB-11B3CAC35229Q47235472-FE00ECB9-18F1-4E8A-894B-6B293C702600Q47259082-DDFF8ACE-1EDA-4071-A846-DD52B3A583EDQ47441583-1F001C7C-0018-4799-9165-0EBF1AE2CF05Q48024919-B963D5B5-9973-4792-BD8A-B8B4B2477C7AQ48354848-D058F4BB-AF8F-4DC5-9609-55D3A9CD5EC1Q52564657-AECFFBA1-A36A-43E6-BE9F-3D14293373EDQ55278061-BFD2422B-625B-4096-ADA3-EF66B61EEE09Q55363824-5AF55ED5-E123-4A57-B060-A9D455D640F4Q57099106-69713F41-4B75-4D0A-BAC0-D8F44304AE6FQ57108626-C55D335E-1721-4B00-8D74-2CB972E45F4FQ57109538-8D118896-1CC3-4D98-B044-2A9B648284A7Q57112246-2FCD1AC7-6EAC-46D0-9F71-DC6E8F780D47Q57114440-A54E7BEB-44F2-4EB0-8D7A-B6ED2179C21BQ57114776-0A9C289F-B455-4069-BEC2-3F835E8CF2ABQ58787534-BB17DE3D-FA12-43EA-881B-DFDD18BC1366
P2860
Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Bile Acid Control of Metabolis ...... alcoholic Fatty Liver Disease.
@en
Bile Acid Control of Metabolis ...... alcoholic Fatty Liver Disease.
@nl
type
label
Bile Acid Control of Metabolis ...... alcoholic Fatty Liver Disease.
@en
Bile Acid Control of Metabolis ...... alcoholic Fatty Liver Disease.
@nl
prefLabel
Bile Acid Control of Metabolis ...... alcoholic Fatty Liver Disease.
@en
Bile Acid Control of Metabolis ...... alcoholic Fatty Liver Disease.
@nl
P50
P921
P1433
P1476
Bile Acid Control of Metabolis ...... alcoholic Fatty Liver Disease.
@en
P2093
Oscar Chávez-Talavera
P304
1679-1694.e3
P356
10.1053/J.GASTRO.2017.01.055
P407
P577
2017-02-15T00:00:00Z